Lowest Price Guaranteed From USD 4,799
Pain management devices are an essential part of the multimodal approach to pain management, which extends beyond pharmaceutical interventions. These devices can serve as adjuvants to existing regimens and offer notable benefits, such as minimal to no drug interaction, relative safety, and lack of addiction potential. They include both invasive and noninvasive approaches and can provide temporary pain control, reduce the need for some pain relievers, and improve the quality of life for individuals with chronic pain. Some examples of pain management devices include bioelectric therapy, which relieves pain by blocking pain messages to the brain and prompting the body to produce pain-relieving chemicals called endorphins. Additionally, transcutaneous electrical nerve stimulation devices rely on the gate control theory of pain modulation by providing nonpainful stimulation over the painful area to downregulate or inhibit nociceptive signals. These devices, when used in conjunction with conventional pain-relieving medications, can allow pain sufferers to reduce their dose of some pain relievers by up to 50%. Overall, pain management devices play a crucial role in helping individuals regulate and alleviate pain, contributing to their physical and mental well-being.
This pain management devices market analysis included in depth information on the competitive landscape, leading products, market share of leading device developers, market size and opportunity analysis, recent trends and developments, and future outlook.
The pain management devices market is being driven by several factors contributing to its growth. The increasing prevalence of chronic diseases, such as cancer which requires pre-surgery and post-surgery pain management, has led to a rising demand for nerve and muscle stimulators, contributing to the market growth.
Additionally, the launch of technologically advanced products, increased product demand, and the aging population are predicted to further drive the market. These factors, along with the high prevalence of diabetes, rising geriatric population, and increasing cases of cancer, are key drivers of the pain management devices market growth.
The pain management devices market faces several restraints despite its projected growth. One significant challenge is the strict regulatory constraints hindering the introduction of innovative medical gadgets. Additionally, the market is impacted by product recalls and high procedural costs. In September 2023, FDA issued a class I recall for Abbott’s Proclaim and Infinity neurostimulation systems. Such recalls may require patients to undergo additional surgeries for removal and replacement of devices.
Moreover, drugs are still used as the first line of treatment for pain management, despite their side effects with prolonged use. limiting the growth of the market. Some patients still prefer pain management drugs over devices owing to lack of awareness, which may hinder the market for pain management devices.
The pain management devices market presents significant market opportunities driven by various factors such as the surge in the geriatric population, the availability of innovative pain management devices, and the rise in demand for these devices in developing regions. Furthermore, the market is witnessing advancements in wearable pain management devices, which are proving beneficial in managing chronic pain and are expected to attract new players to the market. The increasing availability and prevalence of both consumer and research-grade wearable devices provide an opportunity to develop novel methods for characterizing patients' pain, identifying new clinical endpoints, and understanding the correlates and causal determinants of pain onset and duration.
Companies are also developing devices for management of acute pain, beyond the traditional chronic pain management focus. Overall, the pain management devices market offers lucrative growth opportunities, driven by technological advancements, increasing investments, and rising demand in both developed and developing regions.
The pain management devices market forecast on the basis of product type (neurostimulation devices, infusion pumps, ablation devices and other products). On the basis of applications (neuropathic pain, musculoskeletal pain, cancer pain, facial pain, migraine and other applications). On the basis of mode of purchase (prescription and over the counter). By geographical regions, the market is analyzed across North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.
Based on product type, the pain management devices market is analyzed across neurostimulation devices, infusion pumps, ablation devices and other products. Neurostimulation devices have been well accepted for pain management, specifically for neuropathic pain. Device developers have made several technological advancements within this segment, with the launch of wireless devices and micro / mini-implants. US based Theranica, received FDA approval for its smartphone-controlled neuromodulation device available on prescription for treatment of migraine in adults and adolescents aged 12 years and over. This is a non-invasive device worn on the upper arm.
In addition to neurostimulators, radiofrequency ablation (RF ablation) devices are also witnessing significant growth. These devices use radio waves to produce a current, which heats the pain causing nerve endings. In 2017, Avanos Medical (earlier Halyard Health) received FDA approval for first RF ablation device named Coolief for management of chronic knee pain associated with osteoarthritis. Medtronic also received FDA approval for its RF ablation device Accurian in 2019.
Based on applications, the pain management devices market is analyzed across neuropathic pain, musculoskeletal pain, cancer pain, facial pain, migraine and other applications. The dominance of the neuropathic pain segment in the pain management devices market can be attributed to the growing geriatric population, where neuropathic pain is most commonly seen. The common types of neuropathic pain include diabetic neuropathy, idiopathic neuropathy, and back and neck pain with neuropathy.
Additionally, the cancer segment is expected to experience the fastest growth rate during the forecast period. The increasing number of cancer patients has heightened the need for pain management devices to alleviate the pain caused by nerve compression, particularly owing to tumor compression and other factors associated with the progression of cancer.
A number of companies / device developers have received approval for devices for nerve pain management. In April 2023, Neuspera Medical received FDA approval for a leadless micro-implant which offers peripheral nerve stimulation. Few transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) neuromodulation devices have been approved for diabetic neuropathy. All these factors will continue to drive the pain management devices market growth over the forecast period.
Based on region, the pain management devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is poised to dominate the pain management devices market owing to its advanced healthcare infrastructure, facilitating convenient access to state-of-the-art pain management devices. Moreover, government initiatives like the Precision Medicine and Affordable Care Act, along with well-structured reimbursement programs, are further fueling market demand. Devices such as neurostimulators have received reimbursement status in the US for chronic pain management.
The region's leadership in this market is attributed to factors such as the presence of established healthcare facilities, a growing elderly population, and a high incidence of chronic pain cases. According to a survey conducted by National Institutes of Health (NIH) the incidence of new chronic pain cases was 52.4 cases per 1000 person / year in 2020. This number is much higher than the incidence of some of the most common chronic conditions including diabetes, depression and hypertension. Given the rising number of older adults, the market is expected to exhibit a higher growth rate, as this region is more susceptible to chronic ailments.
Key market players that are engaged in pain management devices market are (in alphabetical order) Abbott, Baxter International, Boston Scientific, Epic Medical, InfuTronix Solutions, Medtronic, Nipro, Soterix Medical, Stryker and Teleflex. This market report includes an easily searchable excel database of all the pain management devices companies worldwide.
|by Product Type
|by Mode of Purchase
|Key Geographical Regions
|Key Market Players
There has been recent activity in the pain management devices industry and some of the key developments have been mentioned below: